Cataflam and Altace drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cataflam (diclofenac potassium) and Altace (ramipril). Common drug interactions include electrocardiogram repolarisation abnormality among females and abdominal pain upper among males.

The phase IV clinical study analyzes what interactions people have when they take Cataflam and Altace. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Cataflam?

Cataflam has active ingredients of diclofenac potassium. It is often used in pain. eHealthMe is studying from 1,851 Cataflam users. Check the latest studies of Cataflam.

What is Altace?

Altace has active ingredients of ramipril. It is often used in high blood pressure. eHealthMe is studying from 23,681 Altace users. Check the latest studies of Altace.

On Jul, 22, 2026

11 people who take Cataflam and Altace together, and have interactions are studied.

What are the common drug interactions of Cataflam and Altace, by gender? *:

female:

Electrocardiogram repolarisation abnormality
Electrocardiogram st-t change
Gangrene (body tissue dies)
Hyperkinesia (higher than normal levels of potassium in the circulating blood; associated with kidney failure or sometimes with the use of diuretic drugs)
Hypoxia (low oxygen in tissues)
Injury
Mitral valve incompetence (inefficient heart valve)
Myalgia (muscle pain)
Peripheral vascular disorder
Postoperative wound infection

male:

Abdominal pain upper
Acute myocardial infarction (acute heart attack)
Cardiac murmur (an heart sound in valve abnormality)
Chest discomfort
Chest pain
Clonus (series of involuntary, rhythmic, muscular contractions and relaxations)
Cold sweat
Coronary angioplasty
Coronary arterial stent insertion
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)

What are the common drug interactions of Cataflam and Altace, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Influenza like illness
Insomnia (sleeplessness)
Urinary tract infection
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Cardiomegaly (increased size of heart than normal)
Cardiomyopathy (weakening of the heart muscle)
Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
Intracardiac thrombus (presence of a circumscribed mass with heart wall)
Lobar pneumonia (a form of pneumonia that affects a large and continuous area of the lobe of a lung)
Mass

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Abdominal pain
Asthenia (weakness)
Constipation
Drug ineffective
Injection site pain
Muscle cramps (painful sensations caused by muscle contraction)
Sedation

What are the existing conditions these people have? *

Peripartum Cardiomyopathy (deterioration in cardiac function presenting typically between the last month of pregnancy and up to five months postpartum): 2 people, 18.18%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Cataflam and Altace?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously